BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37338906)

  • 1. Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.
    Nollen NL; Ahluwalia JS; Mayo MS; Ellerbeck EF; Leavens ELS; Salzman G; Shanks D; Woodward J; Greiner KA; Cox LS
    JAMA Netw Open; 2023 Jun; 6(6):e2317895. PubMed ID: 37338906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
    Robles GI; Singh-Franco D; Ghin HL
    Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
    JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
    Davis JM; Masclans L; Rose JE
    JAMA Netw Open; 2023 Sep; 6(9):e2332214. PubMed ID: 37682573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol from a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in African Americans who smoke.
    Nollen NL; Cox LS; Mayo MS; Ellerbeck EF; Arnold MJ; Salzman G; Shanks D; Woodward J; Greiner KA; Ahluwalia JS
    Contemp Clin Trials Commun; 2022 Dec; 30():101032. PubMed ID: 36387983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
    Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
    JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
    Baker TB; Piper ME; Smith SS; Bolt DM; Stein JH; Fiore MC
    JAMA; 2021 Oct; 326(15):1485-1493. PubMed ID: 34665204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial.
    Cinciripini PM; Green CE; Shete S; Minnix JA; Robinson JD; Cui Y; Kim S; Kypriotakis G; Beneventi D; Blalock JA; Versace F; Karam-Hage M
    JAMA; 2024 May; 331(20):1722-1731. PubMed ID: 38696203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
    Rose JE; Behm FM
    Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of the effect of nicotine pre-treatment on quitting smoking.
    Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
    Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
    JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial.
    Hawk LW; Tiffany ST; Colder CR; Ashare RL; Wray JM; Tyndale RF; Brandon TH; Mahoney MC
    JAMA Netw Open; 2022 Nov; 5(11):e2241731. PubMed ID: 36367720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.